POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.

Pennsylvania bans insurers from penalizing or charging higher rates for HIV prevention medication users

Original title: An Act prohibiting discriminatory practices against applicants and enrollees under certain insurance policies based on claims or prescriptions involving prophylaxis HIV medication.

Last action · February 24, 2025: Referred to INSURANCE, Feb. 24, 2025Sponsors: Tarik Khan and 23 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

Pennsylvania House Bill 719 prohibits life, disability, and long-term care insurers from denying coverage, limiting benefits, or charging higher rates to applicants or enrollees solely because they use or have been prescribed HIV pre-exposure () or post-exposure () prophylaxis medications. The measure takes effect in 60 days.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

insurance applicants

Applicants cannot be denied coverage, restricted in coverage terms, or charged higher rates due to PrEP or PEP claims.

Directly affected

insurance enrollees

Enrollees are protected from policy cancellations, benefit reductions, or premium adjustments based on PrEP or PEP prescriptions.

Directly affected

insurers

Insurers are prohibited from using PrEP or PEP prescription history to make underwriting or pricing decisions and face regulatory violations if they do so.

Key Facts

  • Insurers are prohibited from denying or canceling insurance coverage solely because an applicant or enrollee uses PrEP or PEP.
  • Insurers cannot limit the amount, extent, or kind of coverage available to individuals based on PrEP or PEP usage.
  • Insurers are barred from charging different or higher premium rates to individuals or groups based on PrEP or PEP claims or prescriptions.
  • Violating this act constitutes unfair discrimination under section 353 of The Insurance Company Law of 1921.
Show all 7 facts
  • Violating this act constitutes unfair methods of competition and deceptive practices under the Unfair Insurance Practices Act.
  • The act applies to life insurance policies, disability policies, long-term care policies, subscriber contracts, certificates, and plans.
  • The act takes effect 60 days after enactment.

Frequently Asked Questions

What types of insurance policies does this bill cover?
The bill covers life insurance policies, disability policies, long-term care policies, subscriber contracts, certificates, and plans offered, issued, or renewed by an insurer.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

1 action
  1. Feb 24, 2025HouseCommittee
    Referred to INSURANCE, Feb. 24, 2025

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

United States Food and Drug Administration
OrganizationUnited States Food and Drug Administration“approves approved PrEP and PEP medications”Map →

Sources

Open source document

www.palegis.us

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy35
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record